A further opportunity for product differentiation is the influenza vaccine manufacturing process. With the exception of Novartis's Madin–Darby canine kidney (MDCK) cell-based vaccine Optaflu ...
Veterinary pharmaceutical companies are focusing on the development of advanced therapeutics to treat and prevent the spread of canine influenza. Vaccines, antiviral medications, and supportive ...
Improving vaccine uptake in children may reduce influenza illness and, subsequently, emergency department and hospital visits in a time of increased respiratory virus co-circulation. HealthDay ...
H5 Influenza Vaccines: What Needs to Be Done to Reduce the Risk of a Pandemic Sep. 4, 2024 — As the global threat of H5N1 influenza looms with outbreaks across species and continents including ...
The estimated effectiveness of at least one dose of the influenza vaccine against emergency department (ED) visits or hospitalization was over 50% across disease severity levels among nearly 16,000 US ...
Scientists Design Workaround That Improves Response to Flu Vaccine Dec. 19, 2024 — Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them ...
Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance ...
Why You Need A Flu Vaccine Every Year The phenomena of antigenic drift and antigenic shift are why public health authorities recommend getting an influenza vaccine each year. Every year ...
Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...